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In vitro prosurvival role for APRIL in tonsillar 
plasma cells. (A) APRIL-receptor expres-
sion on tonsillar plasma cells. The histo-
grams show the expression of the indicated 
receptors on cells from the CD19+CD38high 
cytosplasmic-Ig+ (Cyt-Ig+) subset in the 
top left dot plot (rectangle). Similar results 
were obtained with tonsil cell suspensions 
from 8 patients. (B) CD19+CD38+ and 
CD19+CD38low/– tonsillar B cells (top panel, 
rectangles) were purified and incubated in 
medium containing ACRP-APRIL or con-
trol ACRP, both at 3 μg/ml. The number 
of viable cells was counted by trypan-blue 
exclusion every day for 4 days (bottom 
panel). Data are presented as mean ± SD. 
(C) Intracellular expression of bcl-2, bcl-xL, 
and mcl-1 was analyzed by flow cytometry 
on purified CD19+CD38+ at the initiation of 
the culture and after 4 days of culture with 
ACRP-APRIL or control ACRP. Dotted 
lines correspond to isotype control stain-
ing. (D) Binding of APRILA88 and APRILH98 
to plastic-coated HSPG (1 μg/ml) was 
revealed with the Aprily-5 mAb (1 μg/ml) 
(top panel). CD19+CD38+ tonsillar plasma 
cells were incubated in plastic wells coated 
with HSPG- or HSPG-binding APRILA88 for 
4 days. Intracellular bcl-2 expression was 
analyzed as in C (bottom panel). Data are 
representative of 2 independent experi-
ments performed with 2 different donors. 
Sn, supernatant.
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APRIL-rich niches are formed in subepithelium zone from the 
tonsillar crypt. (A) Presence of APRIL-producing cells (Stalk-1 
staining, 5 μg/ml) in tonsillar crypt epithelium. The arrow indi-
cates a cell stained brightly. (B) Some Stalk-1–stained cells 
in the epithelium have a trilobular nucleus. (C) These Stalk-1+ 
(green) cells coexpress elastase (red, 1 μg/ml). (D) The crypt 
epithelium is composed of keratin 8+ (1/2, red) cells among 
other pan-keratin+ (1/100, green) and (E) syndecan-1+ 
(10 μg/ml, green) epithelial cells. (F) Keratin 8+ (red) and keratin 8– 
crypt epithelial cells produce APRIL (Stalk-1; green). Secreted 
APRIL (red; Aprily-2 staining, 2 μg/ml) is retained on (G) pan-
keratin+ (green) epithelial cells (H) expressing syndecan-1 
(green). The arrow indicates the direction for the crypt lumen. 
(I) Secreted APRIL (red) accumulates at sites distant from 
APRIL-producing cells (green) in the subepithelial zone. Origi-
nal magnification, ×20 (A and I); ×40 (C–H); ×100 (B). Pictures 
shown are representative of more than 10 crypt epithelia from 
patients with recurrent tonsillitis. in, tonsillar parenchyma; out, 
crypt lumen; Pan-Ker, pan-keratin+; Ker-8, keratin 8+; Syn-1, 
syndecan-1+; Ap-2, Aprily-2.
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Plasma cells accumulate in APRIL-rich niches from tonsils. (A 
and B) Plasma cells (green; Ig staining, 5 μg/ml) accumulate 
close to depots of secreted APRIL (red) (A), underneath pan-
keratin+ (red) (B) epithelial cells from the crypt. The arrow indi-
cates the direction for the crypt lumen. (C) CD20+ cells (red; 
5 μg/ml) are excluded from subepithelial zones of plasma cell 
(green) accumulation. (D) Secreted APRIL (red) is associated 
with plasma cells (green). (E) Plasma cells (green) accumulating 
in the subepithelial zone express syndecan-1 (red). (F) Some 
secreted APRIL (red) binds (arrows) to syndecan-1 (green) 
expressed by plasma cells. (G) Ig isotypes (green; 5 μg/ml) 
produced by plasma cells accumulating in APRIL-rich niches 
(red). Original magnification, ×10 (C); ×20 (A and B); ×40 (D, F, 
and G); ×63 (E). Figures shown are representative of 10 tonsils 
from patients with recurrent tonsillitis.
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APRIL-rich niches invaginate deeply into the crypt lumen. Serial 
sections, at a distance of 100 μm apart, of crypt epithelium starting 
in the tonsillar parenchyma and ending in the crypt lumen (images 
A–D) were stained with an anti-Ig (5 μg/ml). Two separate invagi-
nations (plain and dotted lines) containing cytoplasmic Ig+ plasma 
cells are shown. Epithelium shows depots of secreted Ig. Original 
magnification, ×10. Figures shown are representative of 5 tonsils 
from patients with acute tonsillitis.
Figure 5
APRIL-rich niches are also present in human small intestine. (A) APRIL-
producing cells (green) and depots of secreted APRIL (red) are present in 
intestinal villi. Inset shows secreted APRIL (red) dissociating from APRIL-
producing cells (green). (B) Ig isotype (5 μg/ml, green) produced by plasma 
cells accumulating in APRIL-rich niches (red). Original magnification, ×20 
(A); ×40 (A, inset, and B). Figures shown are representative of at least 5 
intestines analyzed.
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Inflammation regulates APRIL produc-
tion in tonsils. (A) A representative 
example of Stalk-1 staining for crypt 
epithelium from control and acutely 
infected tonsils (left and middle panels). 
Quantification of the staining obtained 
in 5 control, 5 chronically, and 5 acutely 
infected tonsils is shown in the right 
panel. (B) APRIL transcription was 
analyzed by 40 cycles of RT-PCR in 
the indicated cells. Actin was used as 
housekeeping gene (left panel). Quan-
titative RT-PCR for APRIL mRNA was 
performed on epithelial HEK cells treat-
ed for 48 hours with PGN (10 μg/ml), 
LPS (100 ng/ml), Loxoribine (250 μg/ml), 
or CpG (10 μg/ml) (right panel). (C–E) A 
representative example of Stalk-1 (C), 
Aprily-2 (D), and anti-Ig (E) stainings is 
shown as in A (left and middle panels). 
Quantification of the number of Stalk-1–
stained neutrophils infiltrating the crypt 
epithelium (C), of the Aprily-2 staining 
(D), and of the number of plasma cells 
(PCs) in the subepithelial crypt area 
is also shown in right panels. Original 
magnification, ×40.
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Mucosal humoral immunity is short lasting in APRIL-deficient mice. 
Groups of APRIL–/– and WT mice were vaccinated orally with OVA. 
Secretion of OVA-specific Ig by gut plasma cells was tested 3 and 6 
weeks after the last vaccination in fecal extracts by ELISA.
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